These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 8011813

  • 21. Hepatitis C and B viruses: the new opportunists in HIV infection.
    Chung RT.
    Top HIV Med; 2006; 14(2):78-83. PubMed ID: 16835462
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Liver disease and HIV. Hepatitis is an ongoing threat.
    Johnson D, Cohen S, Bonacini M.
    Adv Nurse Pract; 2003 Jun; 11(6):63-6, 68, 70. PubMed ID: 12807059
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Fulminant viral hepatitis.
    Fagan EA, Williams R.
    Br Med Bull; 1990 Apr; 46(2):462-80. PubMed ID: 2116214
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Pathogenesis and alpha-2 interferon treatment of chronic hepatitis B].
    Pirotte J.
    Rev Med Liege; 1996 Aug; 51(8):514-21. PubMed ID: 8927872
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J, Ramos B, Toro C, Ríos P, Martínez-Alarcón J, Bottecchia M, Romero M, Garcia-Samaniego J, Soriano V.
    Antivir Ther; 2008 Aug; 13(1):97-102. PubMed ID: 18389903
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Fatty liver disease--mechanism, clinical significance and factors with a special regard to primary hepatotropic viruses].
    Smoliński P, Simon K, Gładysz A, Nowak M, Dolińska-Krajewska B.
    Wiad Lek; 2006 Aug; 59(11-12):834-41. PubMed ID: 17427501
    [Abstract] [Full Text] [Related]

  • 36. Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus.
    Duclos-Vallée JC, Féray C, Sebagh M, Teicher E, Roque-Afonso AM, Roche B, Azoulay D, Adam R, Bismuth H, Castaing D, Vittecoq D, Samuel D, THEVIC Study Group.
    Hepatology; 2008 Feb; 47(2):407-17. PubMed ID: 18098295
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Antiviral therapy of chronic viral hepatitis. ACG Committee on FDA-Related Matters.
    Di Bisceglie AM, Hoofnagle JH.
    Am J Gastroenterol; 1990 Jun; 85(6):650-4. PubMed ID: 2112881
    [No Abstract] [Full Text] [Related]

  • 39. [Post-hepatitis B, B-D and C cirrhosis].
    Marcellin P.
    Rev Prat; 1991 May 01; 41(13):1149-55. PubMed ID: 1905835
    [Abstract] [Full Text] [Related]

  • 40. Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function.
    Padmapriyadarsini C, Chandrabose J, Victor L, Hanna LE, Arunkumar N, Swaminathan S.
    J Postgrad Med; 2006 May 01; 52(2):92-6. PubMed ID: 16679670
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.